Funding for this research was provided by:
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences and Peking Union Medical College (2021-1-I2M-034, 2021-1-I2M-018 and 2016-I2M-1-002)
State Key Laboratory of Drug Research (XDB39040100)
Innovative Research Group Project of the National Natural Science Foundation of China (81971293, 81788101)
National Basic Research Program of China (National Key Research and Development Program of China)
Received: 17 March 2022
Revised: 21 August 2022
Accepted: 2 October 2022
First Online: 7 November 2022
: Ethic approval and consent to participate
: The study was approved by the ethics committee of Peking Union Medical College Hospital. Informed consent forms were obtained from all patients or their families.
: Not applicable.
: The authors declare that they have no competing interests.